Position in CING
as of Sep 30, 2026
· filed Oct 2, 2026
Position Value
$15
+$15 QoQ
Shares Held
3,000
0.0% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1
of 1 holders
Holding Since
Jun 2022
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CING Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Sep 30, 2026GoalVest Advisory LLC holds $931,759 across 10 Biotechnology names. CING ranks #10 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRDF |
Cardiff Oncology, Inc.
|
687,285 | $831,614 | |
| 2 | RPRX |
Royalty Pharma plc
|
534 | $31,164 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
27 | $20,473 | |
| 4 | CAPR |
Capricor Therapeutics, Inc.
|
2,100 | $19,887 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
66 | $15,280 | |
| 6 | VKTX |
Viking Therapeutics, Inc.
|
200 | $6,520 | |
| 7 | IBRX |
ImmunityBio, Inc.
|
500 | $4,720 | |
| 8 | OTLK |
Outlook Therapeutics, Inc.
|
3,000 | $1,720 |
All Filings in CING
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2024-06-30 | $371 | 1,160 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $1,275 | 1,160 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $1,223 | 160 | Shares | Sole | 2024-01-02 | |
| 2023-09-30 | $2,268 | 3,200 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $2,976 | 3,200 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $3,152 | 3,200 | Shares | Sole | 2023-04-03 | |
| 2022-12-31 | $3,200 | 3,200 | Shares | Sole | 2023-01-06 | |
| 2022-09-30 | $2,354 | 2,200 | Shares | Sole | 2022-10-11 | |
| 2022-06-30 | $3,212 | 2,200 | Shares | Sole | 2022-07-06 | |
| No filing history on record for this holder in this stock. | ||||||